Here are four notes:
1. Analysts expect NuVasive to report earnings per share of $0.36 next quarter.
2. In the previous quarter, the company had EPS of $0.32.
3. Some analysts predict NuVasive to post EPS of $1.72 for the current fiscal year, while other more bearish analysts expect $1.45 EPS.
4. Analysts have a 1.4 consensus rating on NuVasive shares.
More articles on devices:
Stryker leads $84M hip & knee orthopedic surgical robot device markets: 5 key points
Disc replacement driving spine industry — KICVentures comments on industry shift: 7 insights
In light of acquisition, Zimmer Biomet joins LDR in push for Mobi-C reimbursement: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
